Tarriff Scott 4
4 · EAGLE PHARMACEUTICALS, INC. · Filed Jan 9, 2023
Insider Transaction Report
Form 4
Tarriff Scott
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2023-01-05$29.26/sh−3,827$111,978→ 1,575,879 total
Footnotes (1)
- [F1]The disposition reported on this Form 4 represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units.